Understanding the effects of the different processing methods on bioactivity will help you make a clinically sound decision when nurturing your fragile patients. Currently, there are no national minimum requirements and standards in place for every milk bank and every manufacturer of human milk-based products. In this 20-minute video, Scott Eaker, Chief Operations Officer, discusses safety initiatives in the industry, importance of bioactivity, and potential clinical outcomes for preterm infants.